When the Chief Executive Officer of a company issues a letter to the shareholders then there is a lot of vital information that can be gleaned by investors.
This morning the Halberd Corporation (OTCMKTS:HALB) stock could come into considerable focus among investors after its Chief Executive Officer William A Hartman issued a letter addressed to the shareholders. In light of this event, it may be a good idea for investors to consider taking a closer look at some of the highlights from the letter in question. The letter started off by noting that the previous quarter had seen the company hit some major organizational and technical achievements.
The CEO listed down some of those achievements in its letter. He noted that the last two antigens of the top ten antigens related to neurodegenerative diseases that it had been working on had been eliminated during the first quarter. The company noted that the antigen elimination methodology that it uses had been able to eliminate the antigens from the cerebral spinal fluid selectively.
The company also noted that it had also added major subject matter experts to its team in order to make its research programs even stronger. On the other hand, the CEO also announced that the company had also been successful in concluding its financial audio and was awaiting the auditor’s signoff on Form 10.
In addition to charting out some of the key goals for the second quarter, Hartman also summarised the current situation at Halberd. He noted that the company was making major progress in relation to the development and research in relation to its extracorporeal process, for which it already holds a patent. Considering the announcements made in today’s letter it is likely that the stock is going to come into focus among investors once again in a big way.
